Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.
about
Immunity against fungi.The Cell Biology of the Trichosporon-Host Interaction.Immune responses to invasive aspergillosis: new understanding and therapeutic opportunities.Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation.Epidemiology of Invasive Fungal Disease in Children.Inborn errors of immunity underlying fungal diseases in otherwise healthy individuals.Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease.The Role of IL-17 in Protection against Mucosal Candida Infections.Molecular and physiological roles of the adaptor protein CARD9 in immunity.Regulation of C-Type Lectin Receptor-Mediated Antifungal Immunity.Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.Prototheca zopfii colitis in inherited CARD9 deficiency.Emerging Aspergillus Species Almost Exclusively Associated With Primary ImmunodeficienciesInherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and AdultsFrequency and Geographic Distribution of Mutations in Patients With Severe Fungal InfectionsCandidiasis of the Central Nervous System in Neonates and Children with Primary ImmunodeficienciesTreatment of AspergillosisHuman CARD9: A Critical Molecule of Fungal Immune SurveillanceA Founder Mutation Disrupts NF-κB Signaling by Inhibiting BCL10 and MALT1 Recruitment and Signalosome Formation
P2860
Q33752362-6A6C20F4-5791-42BF-90AB-43C664BBCB7CQ39260239-A15B8554-655C-48EB-808B-8923F1FCDE19Q39309770-27635778-715D-4B17-BD4C-D707DB8C55DEQ40044232-70F4ACD6-3567-41E4-9B61-AB5B071BE693Q40304463-B3DF0270-4059-47A3-9CBD-D116EA378141Q41996461-E6857418-0DC3-4289-B49F-91654337A2ADQ46263244-7E52A02E-8D76-434C-8975-398EB3EF7083Q47600680-867914AE-FAD8-4AA8-A8A4-093D2A9BD34AQ49184561-DA8B11AB-B8F8-4F85-9C34-7E08ADC1F969Q49911061-1782FAB8-E955-4EF1-A6B7-D14C38473116Q49956875-8433A0DF-FBB6-46B9-B446-1228EA2C5499Q50065065-4DFB8313-B524-4C57-8B88-5934A15396F8Q52585883-E3155CFF-6D87-4E76-BE16-D146942910FEQ56993243-293DA88A-5347-4342-BD47-2E147F2C65A2Q57059323-442343C0-F4F3-464E-9B7C-03F269949A6FQ58122587-814DD582-CB9E-45A2-B1DE-BD37B5B957C9Q58573019-31CEEA67-F1F7-4624-A05D-DF9A6674D2A2Q58765898-F0D53074-5FDF-4A00-A6F4-E4DC0839F7BFQ58799049-61EDD7F8-BA2B-4C98-A463-BC423814FD3BQ59133625-684A8DE8-E82F-4F7F-A793-DE5AFDA29FEB
P2860
Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.
@en
Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.
@nl
type
label
Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.
@en
Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.
@nl
prefLabel
Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.
@en
Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.
@nl
P2093
P2860
P50
P1433
P1476
Extrapulmonary Aspergillus infection in patients with CARD9 deficiency
@en
P2093
Alexandra F Freeman
Amanda L Collar
Bettina Neumayer
Carolyn Henderson
Chokechai Rongkavilit
Constantinos M Mikelis
Dominik Hartl
Janyce A Sugui
Jean K Lim
Joshua D Milner
P2860
P304
P356
10.1172/JCI.INSIGHT.89890
P577
2016-10-20T00:00:00Z